Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

GENE - CHEMICAL INTERACTIONS REPORT

RGD ID: 10438
Species: Mus musculus
RGD Object: Gene
Symbol: Cyp1a2
Name: cytochrome P450, family 1, subfamily a, polypeptide 2
Acc ID: CHEBI:29865
Term: benzo[a]pyrene
Definition: An ortho- and peri-fused polycyclic arene consisting of five fused benzene rings.
Chemical ID: MESH:D001564
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction is comprised of a complex set of reactions and/or regulatory events, possibly involving additional chemicals and/or gene products.
Object SymbolQualifierEvidenceWithReferenceSourceNotesOriginal Reference(s)
Cyp1a2affects metabolic processingEXP 6480464CTDCYP1A2 protein affects the metabolism of Benzo(a)pyrenePMID:16256281
Cyp1a2decreases expressionEXP 6480464CTDBenzo(a)pyrene results in decreased expression of CYP1A2 mRNAPMID:15034205
Cyp1a2increases activityEXP 6480464CTDBenzo(a)pyrene results in increased activity of CYP1A2 proteinPMID:15863256 PMID:18321868
Cyp1a2increases expressionEXP 6480464CTDBenzo(a)pyrene results in increased expression of CYP1A2 mRNA; Benzo(a)pyrene results in increased expression of CYP1A2 proteinPMID:11171528 PMID:11356909 PMID:14562683 PMID:17997381 PMID:18321868 PMID:1849469 PMID:19406224 PMID:19770486 PMID:19896525 PMID:19961161 PMID:20371670 PMID:21715664 PMID:22466549 PMID:31830554 PMID:32417428 PMID:34472326
Cyp1a2multiple interactionsEXP 6480464CTD[Benzo(a)pyrene co-treated with sodium bichromate] results in decreased expression of CYP1A2 mRNA; [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of Benzo(a)pyrene; [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA; AHR protein affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of CYP1A2 mRNA]; Bucladesine affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; Colforsin affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; Curcumin inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein]; Curcumin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; Curcumin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]; Cycloheximide affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of Benzo(a)pyrene]; Lipopolysaccharides inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]PMID:15034205 PMID:18321868 PMID:1849469 PMID:22466549 PMID:22613061 PMID:31830554 PMID:7750161 PMID:8961944
Cyp1a2affects metabolic processingISOCYP1A2 (Homo sapiens)6480464CTDCYP1A2 protein affects the metabolism of Benzo(a)pyrenePMID:20542099
Cyp1a2decreases activityISOCYP1A2 (Homo sapiens)6480464CTDBenzo(a)pyrene results in decreased activity of CYP1A2 proteinPMID:11162773
Cyp1a2decreases expressionISOCYP1A2 (Homo sapiens)6480464CTDBenzo(a)pyrene results in decreased expression of CYP1A2 mRNAPMID:32234424
Cyp1a2increases activityISOCyp1a2 (Rattus norvegicus)6480464CTDBenzo(a)pyrene results in increased activity of CYP1A2 mRNA; Benzo(a)pyrene results in increased activity of CYP1A2 proteinPMID:21505853
Cyp1a2increases activityISOCYP1A2 (Homo sapiens)6480464CTDBenzo(a)pyrene results in increased activity of CYP1A2 proteinPMID:19202560
Cyp1a2increases expressionISOCyp1a2 (Rattus norvegicus)6480464CTDBenzo(a)pyrene results in increased expression of CYP1A2 mRNA; Benzo(a)pyrene results in increased expression of CYP1A2 proteinPMID:16510159 PMID:17973897 PMID:19497421 PMID:22785257 PMID:24657529 PMID:26466350 PMID:37189300 PMID:8902619
Cyp1a2increases expressionISOCYP1A2 (Homo sapiens)6480464CTDBenzo(a)pyrene results in increased expression of CYP1A2 mRNA; Benzo(a)pyrene results in increased expression of CYP1A2 proteinPMID:10496959 PMID:11849738 PMID:12107646 PMID:15056799 PMID:16269432 PMID:16545412 PMID:16970932 PMID:17253728 PMID:18174961 PMID:20106945 PMID:20435083 PMID:20542099 PMID:20553787 PMID:21256954 PMID:21262253 PMID:21802500 PMID:22316170 PMID:30439556 PMID:31087746 PMID:31515600 PMID:31542801 PMID:31830554
Cyp1a2increases hydrolysisISOCYP1A2 (Homo sapiens)6480464CTDCYP1A2 protein results in increased hydrolysis of Benzo(a)pyrenePMID:19919601
Cyp1a2increases metabolic processingISOCYP1A2 (Homo sapiens)6480464CTDCYP1A2 protein results in increased metabolism of Benzo(a)pyrenePMID:2791199
Cyp1a2multiple interactionsISOCyp1a2 (Rattus norvegicus)6480464CTD[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A2 mRNA; [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CYP1A2 mRNA; [Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] affects the expression of CYP1A2 mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of CYP1A2 mRNA; [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A2 mRNA; [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene] results in increased expression of CYP1A2 mRNA; [chrysene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA; [Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein]; [Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; atipamezole inhibits the reaction [Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein]]; atipamezole inhibits the reaction [Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]]; atipamezole promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; atipamezole promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]; Benzo(a)pyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]; Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein; Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein]; Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; Guanethidine inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein]; INS1 protein inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; lead nitrate inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]; Oxygen inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]; Prazosin inhibits the reaction [Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]]; Prazosin promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; Prazosin promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]; Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein]; Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; Sulpiride inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; Wortmannin inhibits the reaction [INS1 protein inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]]PMID:16510159 PMID:18493746 PMID:18711122 PMID:22785257 PMID:24657529 PMID:26466350 PMID:37189300 PMID:8902619
Cyp1a2multiple interactionsISOCYP1A2 (Homo sapiens)6480464CTD2-oxohexyl isothiocyanate inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein]; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A2 mRNA; [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CYP1A2 mRNA; [Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] affects the expression of CYP1A2 mRNA; [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of Benzo(a)pyrene; [CYP1A2 protein results in increased susceptibility to Benzo(a)pyrene] which results in increased mutagenesis of HPRT1 gene; AHR protein affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; alyssin inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein]; Benzo(a)pyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]; Benzo(a)pyrene promotes the reaction [Butyric Acid results in increased expression of CYP1A2 mRNA]; beta Carotene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]; beta-apo-8'-carotenal promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]; Butyric Acid promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; chrysoeriol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; cryptotanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; cryptotanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]; CYP1A2 protein results in increased metabolism of and results in increased activity of Benzo(a)pyrene; dihydrotanshinone I promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; dihydrotanshinone I promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of Benzo(a)pyrene]; kaempferol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; Melatonin inhibits the reaction [CYP1A2 protein results in increased hydrolysis of Benzo(a)pyrene]; Quercetin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; Quercetin inhibits the reaction [beta Carotene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]]; Quercetin inhibits the reaction [beta-apo-8'-carotenal promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]]; Resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; sulforaphane inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein]; tanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; tanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]PMID:10496959 PMID:16970932 PMID:17690111 PMID:18493746 PMID:19202560 PMID:19919601 PMID:20553787 PMID:21256954 PMID:21262253 PMID:27913846 PMID:30439556 PMID:31830554 PMID:32159784 PMID:8961944
Go Back to source page   Continue to Ontology report